Global Heart Failure Software Market, By Type (Knowledge Based, Non-Knowledge Based), Delivery Mode (Web-Based, On-Premises, Cloud-Based Systems), Platform (Standalone, Integrated), Supportive Devices (Tablets, Desktops, Others), Features (Heart Monitoring Activity, Tracking Periodic Tests, Review Progress, Diary Management Tool, Diagnosis and Therapy Monitoring, Others), End User ( Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tenders, Third Party Distribution) – Industry Trends and Forecast to 2031.
Heart Failure Software Market Analysis and Size
The Korea Heart Disease Fact Sheet 2020 highlights a concerning rise in cardiovascular issues. As mortality and hospitalizations increase, the demand for advanced healthcare solutions, such as heart failure software, becomes critical. Addressing this pressing public health challenge requires innovative technologies to enhance cardiac care and manage the escalating cardiovascular risk factors in South Korea.
Data Bridge Market Research analyses that the global heart failure software market which was USD 3,961.05 million in 2023, is expected to reach USD 6,078.97 million by 2031, and is expected to undergo a CAGR of 5.5% during the forecast period of 2024 to 2031. This indicates that the market value. “Heart monitoring activity” segment dominates the feature segment of the global heart failure software market due to widespread adoption of smart wearables. This surge in popularity reflects a growing health-conscious population, significantly boosting demand for heart monitoring technologies. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Heart Failure Software Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Knowledge Based, Non-Knowledge Based), Delivery Mode (Web-Based, On-Premises, Cloud-Based Systems), Platform (Standalone, Integrated), Supportive Devices (Tablets, Desktops, Others), Features (Heart Monitoring Activity, Tracking Periodic Tests, Review Progress, Diary Management Tool, Diagnosis and Therapy Monitoring, Others), End User ( Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tenders, Third Party Distribution)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Medtronic (Ireland), Abbott (U.S.), Oracle (U.S.), 4S DAWN Clinical Software (U.K.), Axis Clinical Software, Inc. (U.S.), CV Medical Software. (U.S.), Boston Scientific Corporation (U.S.), Cardinal Health (U.S.), Joerns Healthcare (U.S.), GE HealthCare (U.S.), ZOLL Medical Corporation (U.S.), CitiusTech Inc (U.A.E), Axis Clinical Software, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Heart failure software is a specialized digital solution designed to aid in the management, monitoring, and analysis of heart failure patients' data. It integrates patient information, facilitates communication among healthcare providers, supports treatment planning, and enhances overall care coordination, contributing to more effective and personalized heart failure management in healthcare settings.
Global Heart Failure Software Market Dynamics
Drivers
- Rising Prevalence Of Heart Failure
The escalating global prevalence of heart failure serves as a catalyst for the heart failure software market. The surging demand for sophisticated solutions to effectively manage and monitor patients reflects the urgency to address this health challenge, propelling the growth of the heart failure software market.
- Telehealth Integration In Monitoring And Personalized Care
The rising prominence of telehealth and remote patient monitoring propels the heart failure software market. Through facilitating continuous monitoring and personalized care, these software solutions integrate seamlessly with telehealth trends, fostering early intervention and improving patient outcomes in the management of heart failure.
Opportunities
- Market Expansion In Emerging Economies
The expanding market in emerging economies, driven by growing awareness of cardiovascular health and a rising demand for advanced healthcare solutions, offers a significant opportunity for developers in the heart failure software market to meet the evolving healthcare needs and contribute to improved patient outcomes in these regions.
- Patient-Centered Care In Personalized And Holistic Approaches
The shift towards patient-centered care models, emphasizing personalized and holistic approaches, creates a strategic opportunity for the heart failure software market. Through tailoring treatments to individual patient needs, these software solutions play a central role in enhancing care delivery and improving outcomes in the management of heart failure.
Restraints/Challenges
- Data Security Concerns Among Healthcare Providers And Patients
Data security concerns pose a significant hurdle for the heart failure software market. Issues surrounding patient data privacy and security erode trust among healthcare providers and patients, impeding the widespread adoption of these solutions. The apprehension regarding data protection becomes a critical barrier to the market's growth and acceptance.
- Regulatory Compliance Create Complexities For Developers And Providers
Regulatory compliance poses a significant challenge for the heart failure software market. Navigating evolving healthcare regulations and ensuring alignment with stringent data protection laws create complexities for developers and providers. Ensuring compliance can be resource-intensive, impacting the uptake and expansion of heart failure software solutions within the healthcare sector.
This global heart failure software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global heart failure software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2022, Osstem Implant announced the relocation of its unlisted subsidiary, Osstem Cardiotec's headquarters, solidifying its position as Korea's premier cardiac stent product manufacturer. This strategic move marks Osstem Cardiotec's commitment to establishing the country's largest production base, signaling a significant leap forward in the cardiac healthcare industry
- In August 2022, VUNO, a medical AI company, secured approval from the South Korean Ministry of Food and Drug Safety for their portable ECG equipment, Hativ Pro. This innovative device, focused on heart rate measurement, seamlessly connects to a mobile app. VUNO's approval underscores advancements in personal healthcare technology and its integration into daily life
- In June 2021, Medtronic initiated the STROKE AF trial, assessing the Reveal LINQ Insertable Cardiac Monitor's superiority in detecting atrial fibrillation. As a leader in cardiovascular medical technology, Medtronic collaborates with top clinicians and researchers to develop innovative solutions. Committed to delivering high-quality products, the company aims to offer clinical and economic value in healthcare
- In October 2020, Medtronic inaugurated its extensive Research and Development center, a pivotal hub for cutting-edge software development and testing in medical mobile apps and engineering research. This strategic move bolstered Medtronic's R&D capabilities, playing a critical role in innovation and the creation of novel products in the field of medical technology
- In June 2020, Abbott partnered with physicians and health systems, prioritizing accessibility of left ventricular assist devices (LVADs). Through comprehensive training initiatives, physicians began implanting Abbott's HeartMate 3, reinforcing its position in the market. This strategic collaboration not only ensured availability but also diversified Abbott's business portfolio, contributing to increased revenue streams
Global Heart Failure Software Market Scope
The global heart failure software market is segmented on the basis of type, delivery mode, platform, supportive devices, features, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Knowledge Based
- Non-Knowledge Based
Delivery Mode
- Web-Based
- On-Premises
- Cloud-Based Systems
Platform
- Standalone
- Integrated
Supportive Devices
- Tablets
- Desktops
- Others
Features
- Heart Monitoring Activity
- Tracking Periodic Tests
- Review Progress
- Diary Management Tool
- Diagnosis and Therapy Monitoring
- Others
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tenders
- Third Party Distribution
Global Heart Failure Software Market Regional Analysis/Insights
The global heart failure software market is analysed and market size insights and trends are provided by country, type, delivery mode, platform, supportive devices, features, end user and distribution channel as referenced above.
The countries covered in the global heart failure software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the heart failure software market, with the U.S. at the forefront. The region's supremacy is attributed to extensive deployment and substantial investments in the healthcare sector. A technologically advanced healthcare landscape and widespread adoption of innovative solutions contribute to the U.S.'s leadership in advancing heart failure software technologies.
Europe dominates the heart failure software market, with Germany leading the region. Fueled by advanced healthcare infrastructure and government prioritization of health and lifestyle, Germany's proactive approach positions it at the forefront of adopting and advancing heart failure software solutions, addressing the evolving healthcare needs of the European region.
Asia-Pacific dominates the heart failure software market, with China at the forefront. The region's growing developing economies and the increasing utilization of heart rate monitoring and tracking instruments contribute to China's prominence, showing its pivotal role in shaping the heart failure software market landscape in Asia-Pacific.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global heart failure software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global heart failure software market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global heart failure software market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Heart Failure Software Market Share Analysis
The global heart failure software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global heart failure software market.
Some of the major players operating in the global heart failure software market are:
- Medtronic (Ireland)
- Abbott (U.S.)
- Oracle (U.S.)
- 4S DAWN Clinical Software (U.K.)
- Axis Clinical Software, Inc. (U.S.)
- CV Medical Software. (U.S.)
- Boston Scientific Corporation (U.S.)
- Cardinal Health (U.S.)
- Joerns Healthcare (U.S.)
- GE HealthCare (U.S.)
- ZOLL Medical Corporation (U.S.)
- CitiusTech Inc (U.A.E)
- Axis Clinical Software, Inc. (U.S.)
SKU-